Results for tag: "Janumet XR"

Janumet XR is a medication used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It is a combination of two drugs, sitagliptin and metformin, and is part of the Endocrine and Metabolic Disorders Drugs market. Janumet XR works by increasing the body's sensitivity to insulin and decreasing the amount of sugar produced by the liver. It is taken orally once daily and is available in both tablet and extended-release tablet form. Janumet XR is a popular medication in the Endocrine and Metabolic Disorders Drugs market due to its effectiveness in treating type 2 diabetes. It is often prescribed as a first-line treatment for type 2 diabetes, as it is effective in controlling blood sugar levels and reducing the risk of long-term complications. Some companies in the Janumet XR market include Merck & Co., Inc., AstraZeneca, and Boehringer Ingelheim. Show Less Read more